Evidence Doesn’t Scratch Substantiation Itch In NAD Review Of MagniLife Gel Pain Relief Claims

National Advertising Division finds Magni Group didn’t support claims made on MagniLife Gel packaging, in direct-mail advertisements and online and in social media “Rapid Pain Relief.”

(Source: Shutterstock/Citeline)

A Texas firm marketing a pain relief gel made with poison ivy rubbed an industry self-regulation group the wrong way by relying on tests on separate ingredients instead of the entire formulation to support its advertising claims.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

Astaxanthin Specialist AstaReal Diversifies With Garlic Supplement For Heart Health

 
• By 

Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.

ProBiotix Health Looks To Next Level In Korea’s $450m Probiotics Market

 
• By 

Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By 

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

Evidence Doesn’t Scratch Substantiation Itch In NAD Review Of MagniLife Gel Pain Relief Claims

 

National Advertising Division finds Magni Group didn’t support claims made on MagniLife Gel packaging, in direct-mail advertisements and online and in social media “Rapid Pain Relief.”

More from HBW Insight

Astaxanthin Specialist AstaReal Diversifies With Garlic Supplement For Heart Health

 
• By 

Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.

Little Industry Opposition To FDA Plan To Remove Synthetic Dyes, Or Agreement They’re Unsafe

 

Dyes and colors which FDA says industries agree should no longer be used aren’t unsafe and are currently used only with the agency’s approval, industry stakeholders say. Center for Science in the Public Interest says the dyes are used “in tens of thousands of foods and beverages that are commonly consumed here in the United States.”

NAD Refers Men’s Hair Color Brand To FTC For Non-Compliance With Fast-Track SWIFT Decision

 

Plano, Texas-based Simpler Hair Color Inc. may face FTC enforcement action after it failed to comply with the National Advertising Division’s recommendations it discontinue the claim, “Rated #1 Men’s Hair Color,” associated with a consumer review website.